Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review.

@article{Mesaros2014AnaplasticLK,
  title={Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review.},
  author={Eugen F Mesaros and Gregory R. Ott and Bruce D. Dorsey},
  journal={Expert opinion on therapeutic patents},
  year={2014},
  volume={24 4},
  pages={417-42}
}
INTRODUCTION Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase from the insulin receptor superfamily, is implicated in the oncogenesis of numerous cancers including anaplastic large-cell lymphoma, non-small-cell lung cancer, diffuse large B-cell lymphoma, inflammatory myofibroblastic tumors, glioblastoma, as well as neuroblastoma. The root cause for these specific cancers has been identified as aberrant ALK kinase activity, which has been shown to be associated with specific gene… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 93 references

Results of a first-in human phase I study of the ALK inhibitor LDK378 in advanced solid tumors [abstract 4400

  • AT Shaw, DR Camidge, E Felip
  • Ann Oncol 2012;23(Suppl
  • 2012
Highly Influential
15 Excerpts

Preparation of pyrrolopyrimidines as inhibitors of FAK and ALK kinases for treatment of cancers and other diseases

  • Abbott Laboratories
  • 2012
Highly Influential
6 Excerpts

Substituted pyridazine carboxamide compounds as kinase inhibitor compounds

  • Xcovery, Inc
  • 2009
Highly Influential
4 Excerpts

Preparation of pyrimidine compounds that inhibit anaplastic lymphoma kinase

  • Amgen, Inc
  • Expert Opin. Ther. Patents
  • 2014
Highly Influential
14 Excerpts

Preparation of imidazo [4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders

  • Cephalon, Inc
  • 2013
Highly Influential
4 Excerpts

Design of 7-amino-6-chloro-3H-imidazo [4,5-b]pyridine scaffold from 5-chloro2,4-diaminopyrimidine pharmacophore: identification of potent inhibitors of anaplastic lymphoma kinase

  • KS Learn, JC Wagner, MS Albom
  • Med Chem Commun
  • 2012
Highly Influential
14 Excerpts

Similar Papers

Loading similar papers…